Correlation Between Morgan Stanley and MAINZ BIOMED

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and MAINZ BIOMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and MAINZ BIOMED into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and MAINZ BIOMED BV, you can compare the effects of market volatilities on Morgan Stanley and MAINZ BIOMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of MAINZ BIOMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and MAINZ BIOMED.

Diversification Opportunities for Morgan Stanley and MAINZ BIOMED

-0.37

Correlation Coefficient

Morgan Stanley  MAINZ BIOMED

Very good diversification

The 3 months correlation between Morgan and MAINZ is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and MAINZ BIOMED BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAINZ BIOMED BV and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with MAINZ BIOMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAINZ BIOMED BV has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and MAINZ BIOMED go up and down completely randomly.

Pair Corralation between Morgan Stanley and MAINZ BIOMED

Given the investment horizon of 90 days Morgan Stanley Direct is expected to generate 0.19 times more return on investment than MAINZ BIOMED. However, Morgan Stanley Direct is 5.4 times less risky than MAINZ BIOMED. It trades about 0.03 of its potential returns per unit of risk. MAINZ BIOMED BV is currently generating about -0.03 per unit of risk. If you would invest  1,907  in Morgan Stanley Direct on September 26, 2024 and sell it today you would earn a total of  194.00  from holding Morgan Stanley Direct or generate 10.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	46.23%
Values	Daily Returns

Morgan Stanley Direct  vs.  MAINZ BIOMED BV

Morgan Stanley Direct

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.

MAINZ BIOMED BV

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in MAINZ BIOMED BV are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, MAINZ BIOMED reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and MAINZ BIOMED

The main advantage of trading using opposite Morgan Stanley and MAINZ BIOMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, MAINZ BIOMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAINZ BIOMED will offset losses from the drop in MAINZ BIOMED's long position.

The idea behind Morgan Stanley Direct and MAINZ BIOMED BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..